Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02845323
Title Neoadjuvant Nivolumab With and Without Urelumab in Patients With Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma of the Bladder
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

bladder urothelial carcinoma

Therapies

Urelumab

Nivolumab + Urelumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Institute of Urologic Oncology Los Angeles California 90095 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Johns Hopkins Hospital Baltimore Maryland 21205 United States Details
Columbia University Medical Center New York New York 10032 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field